Explore by Disease Group
Select a category below to access curated resources, the latest research, and treatment information.
Patient & Caregiver Resources
Navigating a leukemia diagnosis and treatment is a challenging journey. We provide clear, accessible resources to help you understand blood production, genetic mutations, transplant procedures, and how to interpret your medical reports.
Understand Your Pathology Report
Use our interactive Mutation Explorer to translate complex genomic findings from your test results into clear risk categories and actionable next steps.
Recent Breakthroughs in Leukemia Research
Advances in targeted therapies, immunotherapy, and precision medicine are creating new hope for patients and families.
FDA Approves First Menin Inhibitor for Leukemia
Revumenib (Revuforj), approved in October 2025, is the first oral menin inhibitor for patients with relapsed or refractory AML and ALL harboring KMT2A or NPM1 mutations—offering a targeted option with fewer side effects than traditional chemotherapy.
Source: U.S. FDAGene-Edited CAR-T Achieves 82% Remission in T-ALL
The BE-CAR7 trial using base-edited "universal" CAR-T cells showed deep remissions in aggressive T-cell ALL, with 64% of patients remaining disease-free for up to three years—a remarkable advance for a historically difficult-to-treat leukemia.
Source: University College LondonNew Personalized CAR-T Therapy Available for B-cell ALL
Obe-cel, a next-generation CAR-T therapy, achieved 77% remission in patients with relapsed B-cell ALL. Notably, it demonstrated lower toxicity and fewer severe side effects than existing CAR-T options, offering a safer treatment path.
Source: Blood Cancer UKCombination Therapies Improving Quality of Life
Data presented at ASH 2025 showed that azacitidine + venetoclax for AML led to fewer serious infections, less time in the hospital, and better overall quality of life—demonstrating that modern therapies can be both effective and more tolerable.
Source: eCancer / ASH 2025AI-Powered Research for Everyone
Don't let medical jargon stand in your way. Our suite of AI tools helps you find exactly what you need.
Smart Search
Ask questions in plain English and find matching articles instantly.
Research Insights
AI-generated summaries across hundreds of scientific studies.
Give the Gift of Life
Blood cancer patients often rely on bone marrow transplants and blood transfusions to survive. You can make a difference by joining the donor registry or donating blood.
Join the Bone Marrow Registry
Every 3 minutes, someone is diagnosed with a blood cancer. For many, a bone marrow transplant is their best chance at survival. Joining the registry is simple—just a quick cheek swab.
Register Now
Donate Blood
Blood transfusions are critical for patients undergoing chemotherapy and transplant procedures. A single donation can save up to 3 lives.
Find a Blood Drive